Latest news and press releases about Quanterix Corporation (QTRX): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems are designed to enhance precision health in both scientific research and diagnostic applications, reaching markets across North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
Price
| Price | $2.91 |
| Market Cap | $137M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.59 |
| EV / EBITDA | -1.00 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -43.59% |
| Return on Invested Capital | -46.86% |
| Return on Assets | -38.52% |
| Gross Margin | 42.60% |
| Operating Margin | -86.19% |
| Net Margin | -80.29% |
Related companies: CVRX · IMRX · INGN · MASS · NNOX · OM · SENS
Explore sector: Healthcare · Medical - Devices
More sections of QTRX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks